Andesa Financial Management’s AstraZeneca AZN Stock Holding History

Andesa Financial Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$369K	Buy	4,512 +303	+7%	+$40.8K	0.19%	84
2022 Q4	$571K	Sell	4,209 -492	-10%	-$61.7K	0.31%	80
2022 Q3	$515K	Buy	4,701 +267	+6%	+$33.9K	0.18%	87
2022 Q2	$586K	Buy	4,434 +83	+2%	+$10.9K	0.37%	66
2022 Q1	$577K	Buy	4,351 +950	+28%	+$114K	0.31%	71
2021 Q4	$396K	Sell	3,401 -501	-13%	-$59K	0.19%	102
2021 Q3	$468K	Buy	+3,902	New	+$454K	0.25%	89

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Andesa Financial Management's AZN Position: Q1 2023 in Review

Andesa Financial Management increased its AstraZeneca (AZN) stake by 7.2% in Q1 2023, buying an estimated $40.8K and bringing the position to 4,512 shares worth $369K. The position accounts for 0.19% of the portfolio, ranked #84.

Andesa Financial Management first reported a position in AZN in Q3 2021 and has held it in 7 quarters since. The position peaked at $586K in Q2 2022. 1,056 funds tracked by Wall St. Rank hold AZN as of Q1 2023.

Andesa Financial Management held 4,512 shares of AstraZeneca worth $369K as of Q1 2023.
Andesa Financial Management bought 303 AstraZeneca shares in Q1 2023, an estimated $40.8K.
AstraZeneca made up 0.19% of Andesa Financial Management's portfolio in Q1 2023, its #84 holding.
Andesa Financial Management first reported a position in AstraZeneca in Q3 2021 and has held it in 7 quarters since.
Andesa Financial Management's AstraZeneca position peaked at $586K in Q2 2022.
1,056 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2023.

Based on Andesa Financial Management's 13F filing for Q1 2023, filed 5 May 2023.